FdaApplication
NDA 215499
Identifiers
- fda_app_no: NDA215499
Properties
| Property | Value |
|---|---|
| applicant_name | VIIV HEALTHCARE CO |
| application_type | NDA |
| approval_date | 2021-12-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APRETUDE | CABOTEGRAVIR | 600MG/3ML (200MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
1 product